Information
About
Contacts
Important Dates
Virtual Event
Programme
Scientific Programme
Committees
Abstracts
Registration
Sponsors
Menu
Information
About
Contacts
Important Dates
Virtual Event
Programme
Scientific Programme
Committees
Abstracts
Registration
Sponsors
CELCC 2020
- Virtual Event
The stream will start on Friday 27th of November at 12:30pm
Download
CELCC 2020
App:
Stream and app sponsored by:
CELCC 2020
- Additional materials
Abstracts
Lectures
Posters
Abstracts
Berzinec_P.pdf
Cvek_J.pdf
Filipits_M.pdf
Galffy_G.pdf
Havel_L.pdf
Hoda_A.pdf
Jassem_J.pdf
Kerpel-Fronius_A.pdf
Klastersky_J.pdf
Klikovits_T.pdf
Krejci_D.pdf
Kubes_J.pdf
Lambert_L.pdf
Marusic_A.pdf
Nemejcova_K.pdf
Ostoros_G.pdf
Pirker_R.pdf
Prosch_H.pdf
Soumarova_R.pdf
Svaton_M.pdf
Spisek_R.pdf
Timar_J.pdf
Zemanova_M.pdf
Zogala_D.pdf
Lectures
27. 11. 2020 Opening session
Opening remarks
Luboš Petruželka (CZE)
27. 11. 2020 Opening session
Statistics in clinical trials and medical research
Ondřej Májek (CZE)
27. 11. 2020 Session I
Management of small lung nodules
Helmut Prosch (AUT)
27. 11. 2020 Session I
Circulating biomarkers in early detection and treatment of lung cancer
Filip Janků (USA)
27. 11. 2020 Session I
Pilot screening project in the Czech Republic
Jiří Votruba (CZE)
27. 11. 2020 Session I
Experience with screening in Croatia
Ante Marušić (CRO)
27. 11. 2020 Session I
HUNCHEST screening in Hungary
Anna Kerpel-Fronius (HUN)
27. 11. 2020 Session I
Panel discussion
27. 11. 2020 Satellite symposium I
ROCHE
27. 11. 2020 Session II
Artificial intelligence in imaging
Lukáš Lambert (CZE)
27. 11. 2020 Session II
New technologies in imaging
David Zogala (CZE)
27. 11. 2020 Session II
Next generation sequencing in diagnosis: indications and utilization rate
Jószef Tímár (HUN)
27. 11. 2020 Session II
Predictive biomarkers for the treatment of NSCLC
Kristýna Němejcová (CZE)
27. 11. 2020 Special session
Conquering lung cancer in Central Europe
Jean Klastersky (BEL)
28. 11. 2020 Session III
Minimally invasive surgery
Mir Alireza Hoda (AUT)
28. 11. 2020 Session III
Proton radiotherapy in early stage of lung cancer treatment
Jiří Kubeš (CZE)
28. 11. 2020 Session III
Stereotactic radiotherapy of NSCLC
Jakub Cvek (CZE)
28. 11. 2020 Session III
The role of radiotherapy fractionation
Karin Dieckmann (AUT)
28. 11. 2020 Session IV
Care of patients with Non-Small-Cell lung cancer stage III – the Central European real-world experience – final analysis
Milada Zemanová (CZE)
28. 11. 2020 Session IV
Patient case study: tratment variability in N2 positive stage III NSCLC
Daniel Krejčí (CZE)
28. 11. 2020 Session IV
Adjuvant therapy of resected NSCLC
Robert Pirker (AUT)
28. 11. 2020 Session IV
Induction therapy followed by surgery in NSCLC
Renata Soumarová (CZE)
28. 11. 2020 Session IV
Definitive chemoradiotherapy
Jacek Jassem, Poland
28. 11. 2020 Session IV
Panel discussion
28. 11. 2020 Satellite symposium II
Bristol Myers Squibb
28. 11. 2020
Session V
Immunotherapy beyond checkpoint inhibitors
Radek Špíšek (CZE)
28. 11. 2020
Session V
Atezolizumab in metastatic lung cancer – current evidence
Libor Havel (CZE)
28. 11. 2020
Session V
Durvalumab (metastatic non small cell lung cancer)
Gyula Ostoros (HUN)
28. 11. 2020
Session V
Nivolumab
Helena Linardou (GRE)
28. 11. 2020
Session V
Pembrolizumab
Luboš Petruželka (CZE)
28. 11. 2020
Session V
Panel discussion
28. 11. 2020
Session VI
EGFR mutation-positive NSCLC: recent advances
Krisztina Bogos (HUN)
28. 11. 2020
Session VI
Liquid biopsy for disease monitoring
Martin Filipits (AUT)
28. 11. 2020
Session VI
Targeted therapies of mutation-positive NSCLC
Nir Peled (ISR)
29. 11. 2020
Session VII
Agressive pulmonary adenocarcinoma with new FGFR translocation and cMET mutation not responsive to crizotinib and nintedanib treatment – a case report
Martin Svatoň (CZE)
29. 11. 2020
Session VII
Multidisciplinary management in stage III NSCLC
Thomas Klikovits (AUT)
29. 11. 2020
Session VII
Successful multivariate treatment of stage IV EGFR Exon-19 mutant pulmonary adenocarcinoma
Gabriella Gálffy (HUN)
29. 11. 2020
Session VIII
Small cell lung cancer: treatment advances
Nevena Sečen (SRB)
29. 11. 2020
Session VIII
Malignant pleural mesothelioma: treatment advances
Marko Jakopović (CRO)
29. 11. 2020
Session VIII (Posters)
Definitive chemoradiotherapy of locally advanced Non-Small Cell Lung Cancer (LA-NSCLC) with IGRT technique using tomotherapy HD – updated analysis
Stanislav Hloušek et al (CZE)
29. 11. 2020
Session VIII (Posters)
The role of serum tumour markers in the detection of malignant lung tumours
Martin Skála et al (CZE)
29. 11. 2020
Session VIII (Posters)
Impact of concomitant medication administered at the time of initiation of the outcome of nivolumab therapy in Non-Small Cell Lung Cancer
Martin Svatoň et al (CZE)
29. 11. 2020
Session VIII (Posters)
Examination of the immune cells profile of NSCLC patients indicated for inhibitory checkpoint immunotherapy
Jan Špaček et al (CZE)
29. 11. 2020
CELCC 2020 Farewell:
Closing Remarks
Lubos Petruželka (CZE) Robert Pirker (AUT) Gyula Ostoros (HUN)
Recording partner:
Posters
Hlousek-S_poster.pdf
Skala-M_poster.pdf
Spacek-J_poster.pdf
Svaton-M-poster.pdf